- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07561762
THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY
THE EFFECTIVENESS OF THE I-PASS COMMUNICATION METHOD ON NURSE PERCEPTION OF HANDOVER QUALITY IN THE INPATIENT WARD OF WELAS ASIH HOSPITAL, WEST JAVA PROVINCE
The goal of this non-clinical study is to determine whether the I-PASS communication method influences the improvement of handover quality among nurses. The main questions it aims to answer are:
What are the perceptions of handover quality prior to implementing the I-PASS method? What are the perceptions of handover quality after using the I-PASS method? How do nurse characteristics (gender, age, education, employment status, length of service, and clinical nurse level) affect the improvement of handover quality perceptions when using the I-PASS method? What is the implementation retention of the I-PASS communication method? Is there a significant effect of the I-PASS communication method on nurses' perceptions of handover quality?
Participants will:
Participate in training sessions regarding the I-PASS communication method. Implement the I-PASS method during handover processes for two weeks. Complete questionnaires to assess handover quality.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
West Java
-
Bandung, West Java, Indonesia, 40191
- Welas Asih General Hospital West Java Province
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- General practitioner nurses who working in the internal ward
- General practitioner nurses with a minimum of 6 months of the clinical experience
Exclusion Criteria:
- Clinical nurse manager / leader who did not provide nursing care (e.g Head nurse)
- Nurses on leave
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Training I-PASS handoff bundle
Partisipant in experimental arms will receive I-PASS handoff bundle into daily nursing process for 2 weeks
|
The intervention proceeds of Training I-PASS handoff bundle in three phases: preparation, training, and evaluation.
First, eligible nurses are recruited, provided with informed consent, and grouped by shifts.
After a baseline assessment, participants undergo two 90-minute training sessions over two weeks.
Next, the I-PASS method is implemented for 14 days, with compliance monitored through direct shift-based observations and checklists.
Handover quality is measured via the Handover Evaluation Scale (HES) at three intervals: pre-test (baseline), mid-point (week two), and post-test (week three).
Continuous researcher monitoring ensures protocol fidelity throughout the process.
|
|
Ingen inngripen: SBAR
The control group continues to utilize the hospital's existing standard operating procedure, the SBAR (Situation, Background, Assessment, Recommendation) method, observed two weeks not training I-PASS handoff bundle
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Handover Quality
Tidsramme: two weeks
|
Handover quality measure by the handover evaluation scale instrument
|
two weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Agnes Stephania Penu, BSN, MSc, RN, Faculty of Nursing, Universitas Padjadjaran
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- NURS-202604.01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .